The Analysis Of Yunnan Small And Medium-Sized Biological Pharmaceutical Corporate Finance

The biological pharmaceutical modern biological technology will be the new century the most the prospects of development of new and high technology fields, it is in the world recognized as "sunrise enterprise", is a matter of national economy and people’s livelihood strategic industry, and the related biological pharmaceutical industry also prospects the infinite. Yunnan province has innate resource advantages, and the biological pharmaceutical field has the advantageous conditions. But the financing problem has been troubling yunnan small and medium-sized biological pharmaceutical enterprise, this also is in the present yunnan or even Chinese small and medium-sized biological pharmaceutical enterprise development the main reason behind.This paper mainly expounds the biological pharmaceutical industry at home and abroad, the status quo and developing trend. And use quantity research and comparative method in our province will be biological pharmaceutical enterprise financing mode and compare both at home and abroad, the search disparity. Yunnan small and medium-sized biological pharmaceutical enterprise in solving the financing problem is main or rely on entrepreneurial self-raised funds and national science and technology subsidies, but these funds can’t meet the biological pharmaceutical enterprise development needs.This paper also analyzes the impact of our country, our province biological pharmaceutical financing main reason, and on this basis puts forward some reasonable Suggestions and financing strategy. Abundant financing structure, expand the financing channels is the future our province small and medium-sized biological pharmaceutical enterprise financing to the primary problem. The risk investment and financing should be listed on the gem is small and medium-sized enterprise positive development target, in addition, the bank loans will strive for as far as possible.